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Background
Mannitol challenge is becoming a supplementary and
suitable method for the assessment of asthma, commonly
used for the diagnosis of Exercise-Induced Asthma, due
to its safety and high specificity, demanding less equip-
ment and time requirement. Some studies show a closer
relationship between AHR (Airway Hyperresponsiveness)
to mannitol and markers of airway inflammation com-
pared with AHR to methacholine in a selected group of
asthmatic subjects. We aimed to describe its suitability in
a group of patients who were referred to our outpatient
clinic with asthma suspicion.
Methods
Forty-eight patients over 14 years old from our Allergy
Department with asthma symptoms (dyspnoea, cough or
wheezing) enrolled in the study. Mannitol was inhaled
according to manufacturer instructions (Dr. Anderson 9-
Step protocol). The study included skin prick testing with
a battery of common aeroallergens and respiratory func-
tion tests. All patients gave written informed consent.
Results
Forty-eight patients (27 female; 21 male) with a mean age
of 30.61 years old were enrolled in the study. Forty
patients were atopic (95.24%), showing at least one posi-
tive skin prick test and/or aeroallergen specific IgE. Two
patients did not show any positive skin prick test nor
aeroallergen-specific IgE. Twenty-two patients (45.83%)
had a positive Mannitol Test with a mean PD15 of 155
mg. Mean Fractional exhaled nitric oxide (FeNO) of the
former resulted 36.1 ppb. Six patients (27.27%) exhibited
a rapid response to Mannitol challenge and were classi-
fied as severe AHR. Five patients (22.72%) showed a
moderate response to Mannitol (Steps 5-6). Eleven
patients (50%) exhibited a mild response to Mannitol
(Steps 7-9). All patients who manifested AHR after Man-
nitol Test presented a rapid recovery (<10 minutes) to
baseline FEV1 after Salbutamol inhalation. The mean
time required to complete the test was 18 minutes.
Conclusions
Mannitol might be considered as a convenient method
for AHR diagnosis, due to its good safety and time-sav-
ing profile, specificity and relatively low equipment
requirement.
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